Sandbox:patho3

Revision as of 16:47, 13 October 2015 by Haytham Allaham (talk | contribs)
Jump to navigation Jump to search

Pathogenesis

  • Chronic lymphocytic leukemia arises from pre-follicular center B cells, that are normally involved in the process of human immunoglobulins production.
  • Malignant lymphocytic cells infiltrates hematopoietic sites such as the bone marrow where they interfere with the production of normal blood cells.
  • Chronic lymphocytic leukemia may also infiltrate the lymph nodes, spleen, and liver.[1]
  • Immune deficiency may occur in chronic lymphocytic leukemia as the majority of cases develop hypogammaglobulinemia.[2]
  • Warm autoimmune hemolytic anemia may develop due to the production of IgA and IgG autoantibodies among certain cases of chronic lymphocytic anemia.
  • Richter's transformation may occur among 1-5% of chronic lymphocytic leukemia cases.[1]
  • Richter's transformation represents the conversion of chronic lymphocytic leukemia into a more aggressive, rapidly growing large B cell lymphoma.

Genetics

  • Development of chronic lymphocytic leukemia is the result of multiple genetic mutations that promote leukemic proliferation and apoptotic resistance of mature B cells.[3]
  • Genes involved in the pathogenesis of chronic lymphocytic leukemia include:[1][3]
  • Chromosome 13q deletion (most common genetic mutation)
  • Chromosome 17p deletion
  • Chromosome 11q deletion
  • Trisomy 12
  1. 1.0 1.1 1.2 Chronic Lymphocytic Leukemia (2015) https://en.wikipedia.org/wiki/B-cell_chronic_lymphocytic_leukemia Accessed on October 12, 2015
  2. Nabhan C, Rosen ST (2014). "Chronic lymphocytic leukemia: a clinical review". JAMA. 312 (21): 2265–76. doi:10.1001/jama.2014.14553. PMID 25461996.
  3. 3.0 3.1 Hallek M (2015). "Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment". Am J Hematol. 90 (5): 446–60. doi:10.1002/ajh.23979. PMID 25908509.